欧洋,沈伟,施海明

• 1:复旦大学附属华山医院心内科

摘要(Abstract)：

<正>经皮冠状动脉介入治疗(percutaneouscoronary intervention,PCI)是恢复冠状动脉有效血运的主要手段,使患者获益明显。2018年4月全国介入心脏病学论坛(CCIF)公布了2009-2017年中国大陆PCI患者数,从公布的数据上看PCI术数量逐年上升。在成功血运重建患者中,排除急性冠状动脉综合征、心力衰竭、瓣膜病等后,仍有高达30%患者存在持续心绞痛和(或)劳力诱发心肌缺血的证据~([1])。还有一部分患

关键词(KeyWords)： 经皮冠状动脉介入治疗;冠状动脉微循环障碍;心肌梗死

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金面上项目(81673701、81573710);; 上海市科学技术委员会科研计划项目中医类引导项目(15401932000);; 上海市卫生和计划生育委员会中医药科研基金(2014JZ006A)

作者(Author): 欧洋,沈伟,施海明

参考文献(References)：

• [1] Marzilli M, Huqi A, Morrone D. Persistent angina:the araba phoenix of cardiology. Am J Cardiovasc Drugs, 2010,10(Suppl 1):27-32.
• [2] Shome JS, Perera D, Plein S, et al. Current perspectives in coronary microvascular dysfunction. Microcirculation, 2017,24(1).
• [3] Sones FM Jr. Cine-cardio-angiography. Pediatr Clin North Am,1958,5(4):945-979.
• [4] Favaloro RG, Effler DB, Groves LK, et al. Severe segmental obstruction of the left main coronary artery and its divisions.Surgical treatment by the saphenous vein graft technique. J Thorac Cardiovasc Surg, 1970,60(4):469-482.
• [5] Grüntzig A, Schneider HJ. The percutaneous dilatation of chronic coronary stenoses--experiments and morphology. Schweiz Med Wochenschr, 1977,107(44):1588.
• [6] Kemp HG Jr. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol, 1973,32(3):375-376.
• [7] Cannon RO 3rd, Epstein SE."Microvascular angina"as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol, 1988,61(15):1338-1343.
• [8] Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med, 2007,356(8):830-840.
• [9] Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease:the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J, 2013,34(38):2949-3003.
• [10] Lansky AJ, Pietras C. Coronary microvascular dysfunction:does sex matter? JACC Cardiovasc Interv, 2015,8(11):1442-1444.
• [11] Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction(2018). Circulation, 2018, 138(20):e618-e651.
• [12] Garcia MJ, McNamara PM, Gordon T, et al. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes, 1974,23(2):105-111.
• [13]李萌玫,邵一兵,张纯全,等. 2型糖尿病血糖控制不良合并急性心肌梗死患者择期经皮冠状动脉介入治疗后冠状动脉微循环及近期预后.中国介入心脏病学杂志, 2017, 25(11):628-633.
• [14] Tardiff BE, Califf RM, Tcheng JE, et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin(eptifibatide)to Minimize Platelet Aggregation and Coronary Thrombosis-II. J Am Coll Cardiol, 1999,33(1):88-96.
• [15] Mather K, Laakso M, Edelman S, et al. Evidence for physiological coupling of insulin-mediated glucose metabolism and limb blood flow. Am J Physiol Endocrinol Metab, 2000, 279(6):E1264-E1270.
• [16] Nitenberg A, Valensi P, Sachs R, et al. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes, 1993,42(7):1017-1025.
• [17] Collet JP, Montalescot G. The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2diabetes. Diab Vasc Dis Res, 2005,2(3):136-143.
• [18] Golino P, Maroko PR, Carew TE. The effect of acute hypercholesterolemia on myocardial infarct size and the no-reflow phenomenon during coronary occlusion-reperfusion. Circulation,1987,75(1):292-298.
• [19] Mehran R, Dangas G, Mintz GS, et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions:intravascular ultrasound study of 2256 patients. Circulation, 2000,101(6):604-610.
• [20] Kanaparti PK, Brown DL. Relation between coronary atherosclerotic plaque burden and cardiac enzyme elevation following percutaneous coronary intervention. Am J Cardiol, 2000, 86(6):619-622.
• [21] van Gaal WJ, Ponnuthurai FA, Selvanayagam J, et al. The syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol, 2009, 135(1):60-65.
• [22] Stone GW, Maehara A, Muller JE, et al. Plaque characterization to inform the prediction and prevention of periprocedural myocardial infarction during percutaneous coronary intervention:the CANARY trial(coronary assessment by near-infrared of atherosclerotic rupture-prone yellow). JACC Cardiovasc Interv, 2015,8(7):927-936.
• [23] Babu GG, Walker JM, Yellon DM, et al. Peri-procedural myocardial injury during percutaneous coronary intervention:an important target for cardioprotection. Eur Heart J, 2011,32(1):23-31.
• [24] Ambrosio G, Weisman HF, Mannisi JA, et al. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation, 1989, 80(6):1846-1861.
• [25] Kloner RA, Ganote CE, Jennings RB. The"no-reflow"phenomenon after temporary coronary occlusion in the dog. J Clin Invest, 1974,54(6):1496-1508.
• [26] Bekkers SC, Yazdani SK, Virmani R, et al. Microvascular obstruction:underlying pathophysiology and clinical diagnosis. J Am Coll Cardiol, 2010,55(16):1649-1660.
• [27] Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction:a quantitative review of 23 randomised trials. Lancet, 2003,361(9351):13-20.
• [28] Rezkalla SH, Kloner RA. Coronary no-reflow phenomenon:from the experimental laboratory to the cardiac catheterization laboratory.Catheter Cardiovasc Interv, 2008,72(7):950-957.
• [29] Cuisset T, Hamilos M, Melikian N, et al. Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation. J Am Coll Cardiol, 2008,51(11):1060-1065.
• [30] Burzotta F, Trani C, Prati F, et al. Comparison of outcomes(early and six-month)of direct stenting with conventional stenting(a meta-analysis of ten randomized trials). Am J Cardiol, 2003, 91(7):790-796.
• [31] Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation, 2002,105(11):1285-1290.
• [32] Laskey WK. Beneficial impact of preconditioning during PTCA on creatine kinase release. Circulation, 1999, 99(16):2085-2089.
• [33] Hoole SP, Heck PM, Sharples L, et al. Cardiac remote ischemic preconditioning in coronary stenting(CRISP stent)study:a prospective, randomized control trial. Circulation, 2009, 119(6):820-827.
• [34]曾凯东,谢莲娜,刘灿章,等.肢体远隔缺血适应对成功行经皮冠状动脉介入治疗ST段抬高型心肌梗死患者冠状动脉微循环灌注及血清亚硝酸盐水平的影响.中国介入心脏病学杂志, 2018,26(11):632-637.
• [35] Labinaz M, Ho C, Banerjee S, et al. Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein IIb/IIIa antagonists for percutaneous coronary intervention. Can J Cardiol,2007, 23(12):963-970.
• [36] Landoni G, Biondi-Zoccai GG, Zangrillo A, et al. Desflurane and sevoflurane in cardiac surgery:a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth, 2007,21(4):502-511.
• [37] Desmet WJ, Dens J, Coussement P, et al. Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial. ADEnosine limit myocardial necrosis. Heart, 2002,88(3):293-295.
• [38] Schoenhagen P, Tuzcu EM, Apperson-Hansen C, et al.Determinants of arterial wall remodeling during lipid-lowering therapy:serial intravascular ultrasound observations from the reversal of atherosclerosis with aggressive lipid lowering therapy(REVERSAL)trial. Circulation, 2006,113(24):2826-2834.
• [39] Wang FW, Osman A, Otero J, et al. Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker. Circulation, 2003,107(23):2914-2919.
• [40] Bonello L, Sbragia P, Amabile N, et al. Protective eff ect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention. Heart, 2007,93(6):703-707.
• [41] Mizumura T, Nithipatikom K, Gross GJ. Eff ects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Cardiovasc Res, 1995,29(4):482-489.
• [42]郭文玉,王小庆,邹春霞,等.应用微循环抵抗指数评估尼克地尔对冠脉慢血流的临床疗效.实用中西医结合临床, 2016,16(4):45-46.